RMD
Head of Investor Relations
2023-04-01–present
Head of Investor Relations
Resmed Inc (RMD)Head of Investor Relations
Solventum Corp (SOLV)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Amy Wakeham is recorded as Head of Investor Relations at Resmed Inc (RMD) and Head of Investor Relations at Solventum Corp (SOLV). Resmed Inc reported in an 8-K filed March 30, 2023 that Amy Wakeham was appointed Chief Communications and Investor Relations Officer, effective April 1, 2023. Amy Wakeham has spoken on 24 earnings calls across 2 companies, most recently for Solventum Corp on August 5, 2026.
“Amy Wakeham, ResMed's current Vice President of Corporate Communications & Investor Relations, has been appointed Chief Communications and Investor Relations Officer to succeed Pendarvis in his role leading corporate public affairs; she will report to the Office of the CEO and will join ResMed's executive leadership team, effective April 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
SEC 8-K
2023-04-01–present
Recorded roles and call appearances connecting this person to public companies.
RMD
Head of Investor Relations
2023-04-01–present
SOLV
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.